- 310. Longitudinal Assessment of Point|of|Care LumiraDx Antigen ...🔍
- Poster Abstracts • OFID 2022:9 🔍
- Performance of the LumiraDx Microfluidic ...🔍
- SARS|CoV|2 screening considerations🔍
- NHS Scotland Assessment of LumiraDx SARS|CoV|2 Ab Test🔍
- Benjamin GRANT🔍
- Positive Predictive Agreement Research Articles🔍
- Jason L Cantera🔍
310. Longitudinal Assessment of Point|of|Care LumiraDx Antigen ...
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen ...
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery.
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen ...
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery. December 2022 ...
Poster Abstracts • OFID 2022:9 (Suppl 2) • S205
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody. Test Performance During Acute SARS-CoV-2 Infection and Recovery. Ronit Dalmat ...
Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 ...
Sources of heterogeneity investigated included setting and indication for testing, assay format, sample site, viral load, age, timing of test, and study design.
Performance of the LumiraDx Microfluidic ... - PubMed
Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children · Authors.
SARS-CoV-2 screening considerations - medRxiv
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2.
NHS Scotland Assessment of LumiraDx SARS-CoV-2 Ab Test
Longitudinal samples were ... Performance evaluation of the LumiraDx SARS-CoV-2 Antigen Test to aid diagnosis of acute COVID-19 at the point of care.
Rapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 ...
Agullo V, Fernandez-Gonzalez M, Ortiz de la Tabla V, Gonzalo-Jimenez N, Garcia JA, Masia M, et al. Evaluation of the rapid antigen test Panbio COVID-19 in ...
Benjamin GRANT | Doctor of Philosophy | Research profile
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery. Article. Full ...
Positive Predictive Agreement Research Articles - R Discovery
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery. Abstract ...
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery. Ronit R. Dalmat ...
Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in ...
Evaluation of accura- cy, exclusivity, limit-of-detection and ease-of-use of. LumiraDx™: an antigen-detecting point-of-care device for SARS-CoV- ...
Accuracy of rapid point-of-care antigen-based diagnostics for SARS ...
... Antigen Test (LumiraDx, United King-. 417 dom; henceforth called ... assessment of rapid, point-of-care antigen testing for the diagnosis.
Diagnostics and analysis of SARS-CoV-2: current status, recent ...
... (point-of-care). Many immunoassays, referred to as total antibody ... Secondly, although home-based Ag-RDTs have increased antigen testing, Ag ...
Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid ...
... testing and versus the Sofia 2 SARS Antigen Point-of-Care Test. J ... Longitudinal observation and decline of neutralizing antibody ...
Establishment of RPA-Cas12a-Based Fluorescence Assay for Rapid ...
310. Longitudinal Assessment of Point-of-Care LumiraDx Antigen and Antibody Test Performance During Acute SARS-CoV-2 Infection and Recovery. Ronit Dalmat ...
COVID-19 Pandemic: Review of Contemporary and Forthcoming ...
One such promising molecular point-of-care test method includes Isothermal Nucleic Acid Amplification Techniques. ... antigen testing in ...
Clinical and experimental factors that affect the reported ...
29d, LumiraDx™ SARS-CoV-2 Ag Test, LumiraDx, United Kingdom, Roche ... testing and versus the Sofia 2 SARS Antigen point-of-care test. J ...
The current state of SARS-CoV-2 antibody tests and their future ...
A study profiling early humoral response demonstrated that IgA and IgM antibodies can be detected as early as five days after infection, with levels increasing ...
Journal of Clinical Virology - Hvidovre Hospital
seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory. 223 evaluation study., The Lancet. Microbe. 2 ...